AI assistant
PFIZER INC — Director's Dealing 2014
Feb 28, 2014
29831_dirs_2014-02-28_2fd97361-63c4-4384-8ef0-e028bf34b063.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2014-02-26
Reporting Person: YOUNG JOHN D (Group President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-26 | Common Stock | M | 57586.0000 | $12.7000 | Acquired | 116884.0000 | Direct |
| 2014-02-26 | Common Stock | A | 16145.0000 | $0.0000 | Acquired | 133029.0000 | Direct |
| 2014-02-26 | Common Stock | F | 7642.0000 | $31.9900 | Disposed | 125387.0000 | Direct |
| 2014-02-26 | Common Stock | F | 44874.0000 | $31.9900 | Disposed | 80513.0000 | Direct |
| 2014-02-27 | Common Stock | A | 28134.0000 | $0.0000 | Acquired | 108647.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-26 | Stock Appreciation Rights | $12.7000 | M | 39677.0000 | Disposed | 2014-02-26 | Common Stock (39677.0000) | Direct |
| 2014-02-27 | Stock Appreciation Rights | $32.2300 | A | 154374.0000 | Acquired | 2019-02-27 | Common Stock (154374.0000) | Direct |
| 2014-02-27 | Stock Appreciation Rights | $32.2300 | A | 122951.0000 | Acquired | 2021-02-27 | Common Stock (122951.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 870.0000 | Indirect |
| Common Stock | 1279.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
F4: The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon).
F5: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F6: Dividend equivalents are paid on these stock appreciation rights at the time of settlement.
F7: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F8: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.